The major indices closed with a mixed tone after a session of careful balance between safety in value plays and the still-ambitious tilt toward growth. The S&P 500 eked out a gain, the Dow inched into positive territory as fresh macro cues…
In honor of Veterans Day, the market brought both rally and resilience, as portfolio generals weighed AI ambition against time-honored value plays. Whether saluting S&P records or commiserating with Nasdaq laggards, investors marched onward—sometimes in formation, sometimes in hopeful disorder, and always…
Stocks soared Monday, November 10, 2025, with a rally that could make even the most seasoned bear consider a hibernation sabbatical. Wall Street’s major indexes leapt as Congress inched closer to ending the record-breaking government shutdown, unleashing the kind of risk-on mood…
Pfizer, never one to miss a raucous game of pharmaceutical musical chairs, has outmaneuvered Novo Nordisk in a $10 billion dash for Metsera, a company that—at the time of acquisition—boasted more promising obesity drugs in its pipeline than products on pharmacy shelves.…
Wall Street’s week wrapped with less of a bow and more of a sigh, as major indexes retreated under a cloud of AI valuation skepticism, limp labor data, and Capitol Hill’s existential drama over the government shutdown, which cost the economy an…
Wall Street ended Thursday, November 6, 2025, sharply lower as surging volatility and renewed skepticism over tech valuations sent both large and small caps reeling. The Dow Jones Industrial Average finished down 0.84% at 46,912.30, the S&P 500 lost 1.1% to close…
Wall Street ushered in Wednesday, November 5, 2025 with a refreshed dose of optimism—and just a dash of sophisticated exasperation—as major indices snapped back from recent turbulence driven by AI sector jitters and global macroeconomic suspense. The S&P 500 closed at 6,796.29,…
In sum, today's market action reflected deepening caution across asset classes, with macro and policy uncertainties intersecting management commentary for a more sober market tone. Investors are closely watching congressional negotiations on Election Day to end the government shutdown and anticipate further…
Pfizer’s (PFE) move to acquire Metsera (Monday, Sept. 22, 2025) for up to $4.9 billion marks a pivotal expansion in the fast-evolving obesity and diabetes treatment market, intensifying the industry’s GLP-1 rivalry among major pharmaceutical players. Modular Medical (NASDAQ: MODD), with its…
Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…